PMID
int64 27.8M
36.2M
| Title/Abstract
stringlengths 7
10.7k
| MeshTerms
stringlengths 7
104
| SemanticTypes
stringlengths 4
84
|
|---|---|---|---|
34,693,959 | develop copper vacanc defect silver dope cus nanoplatform high effici phototherm chemodynam synergist antitumor therapi combin chemodynam phototherm materi improv therapeut effect chemodynam therapi cdt thermal stimul also play synergist therapeut role benefit strong near infrar absorpt abil copper sulfid cus nanomateri wide use phototherm therapi howev due harsh prepar condit low phototherm effici poor biocompat biomed applic limit work silver dope copper sulfid nanoparticl bsa ag cus synthes use biominer strategi use bovin serum albumin bsa templat stabil silver dope great improv near infrar absorpt phototherm effici cus nanoparticl use nm laser guid phototherm therapi ptt meanwhil bsa ag cus nanoparticl synergist therapeut effect cdt thus show excel antitumor perform vivo vitro biolog experi shown bsa ag cus nanoparticl good stabil low toxic good biocompat strong antitumor abil promis antitumor agent futur clinic cancer treatment | D000076722;D000082703 | T091;T062;T061 |
34,693,955 | explor match degrad ecm base composit tissu remodel full thick abdomin wall defect model repair abdomin wall defect current clinic challeng natur deriv extracellular matrix ecm small intestin submucosa sis receiv great attent abdomin wall defect repair remark bioactiv biodegrad tissu regener match materi degrad tissu remodel import realize ideal repair effect studi near infrar nir fluoresc dye cy nhs ester use label ecm base ecmb composit consist sis chitosanelastin electrospun nanofib monitor materi degrad tissu remodel ecmb composit full thick abdomin wall defect repair systemat investig seri test includ wall thick measur muscl regener analysi angiogenesi assess main find real time noninvas degrad monitor ecmb composit complet degrad could realiz chemic conjug cy nhs ester full thick abdomin wall defect model explant thick could use intuit indic evalu tissu remodel effici ecmb composit accuraci indic verifi various examin includ collagen deposit angiogenesi muscl regener present studi could provid new insight evalu tissu repair effect ecmb composit | D034861;D001672;D048271;D005109 | T023;T121;T109;T122;T024 |
34,693,954 | probe polym brush electrochem imped spectroscopi mini review polym brush frequent use surfac tether antifoul layer biosensor improv sensor surfac analyt recognit presenc abund non target molecul complex biolog sampl suppress nonspecif interact howev brush complex system high respons chang surround environ studi properti remain challeng electrochem imped spectroscopi ei emerg method context mini review aim elucid potenti ei investig physicochem properti structur aspect polym brush applic ei brush base biosensor also discuss common principl employ biosensor present well interpret ei data obtain setup overal demonstr ei polym brush pair consider potenti provid new insight brush function design high sensit specif biosensor | D015374;D058266 | T059;T075 |
34,693,952 | ab initio molecular dynam simul experiment speciat studi levofloxacin differ ph condit levofloxacin extens employ broad spectrum antibiot belong fluoroquinolon class despit extrem wide usag levofloxacin plethora diseas molecular character antibiot appear quit poor literatur moreov acid base properti levofloxacin crucial design effici remov techniqu wastewat never extens investig far report studi behavior levofloxacin standard divers ph condit liquid water synergist employ static quantum mechan calcul along experiment speciat studi furthermor aim character dynam water solvat shell well proton deproton mechan present unpreced quantum base simul levofloxacin aqueous environ mean state art densiti function theori base molecular dynam way prove cooper role play aqueous hydrat shell assist proton transfer event import key place held nitrogen atom bind methyl group levofloxacin accept excess proton eventu present water final also quantifi energet contribut associ presenc h bond intern levofloxacin one hand stabil ground state molecular structur antibiot hinder first deproton step fluoroquinolon among thing synergist employ quantum base calcul speciat experi report pave way toward develop target remov approach drug wastewat | D000077318;D056004 | T044;T170;T066 |
34,693,940 | japanes translat linguist valid prosthet limb user survey mobil plus self report survey instrument use improv clinic care lower limb prosthesi user global scale pool compar health outcom data multipl countri languag translat process critic qualiti compar translat survey instrument | D001186 | T074 |
34,693,939 | comparison bodi structur function activ particip level accord ankl foot orthosi wear time children spastic cerebr palsi ankl foot orthos afo usual recommend prevent deform increas stand walk perform children spastic cerebr palsi cp | D002547;D061826 | T074;T047;T019 |
34,693,938 | rehabilit outcom major lower limb amput oldest old systemat review popul grow older burden chronic diseas increas mani individu undergo major lower limb amput lla advanc age scarciti literatur focus outcom rehabilit peopl acquir lla year age older | D000674;D001186 | T074;T101 |
34,693,937 | content comparison four common use ampute mobil assess scale literatur link intern classif function disabl health despit fact number studi reveal linkag scale world health organ intern classif function disabl health icf need comprehens studi examin relationship ampute mobil scale icf | D000674;D006233 | T101 |
34,693,936 | patellar instabl patella disloc incid patellar instabl pediatr patient rang patient per year risk recurr disloc howev cite depend individu patient factor manuscript highlight demograph histor anatom factor associ recurr patellar instabl follow first time patella disloc pediatr popul | D007593;D031222;D057071 | T033;T030;T037 |
34,693,935 | interrat reliabl pediatr asthma score aim studi determin interrat reliabl irr pediatr asthma score pas evalu discrimin perform score predict need hospit admiss among children acut asthma | D001249;D014218 | T047;T061 |
34,693,934 | pediatr transport safeti collabor advers event parent presenc pediatr critic care transport canada critic ill pediatr patient requir transfer tertiari care center definit medic surgic manag studi suggest famili accompani could compromis care current limit research examin patient safeti outcom pediatr critic care transport famili presenc canada specif data current exist primari object studi compar rate advers event transport pediatr patient special pediatr critic care transport team parent accompani without parent accompani secondari object includ whether geograph patient specif factor affect rate parent accompani parent presenc transport relat patient outcom | D003422;D016638 | T058;T047 |
34,693,933 | brief report differ lopinavirritonavir nonnucleosid revers transcriptas inhibitor base antiretrovir therapi clearanc plasmodium falciparum subclin parasitemia adult live hiv start treatment hiv proteas inhibitor anti plasmodium falciparum activ adult remain uncertain | D019380;D015658;D017320 | T047;T121 |
34,693,932 | random blind placebo control trial de simon formul probiot hiv associ suboptim cd cell recoveri assess whether probiot supplement may reduc diseas link system immun activ peopl live hiv immunolog nonrespond phenotyp | D015658;D019936 | T007;T047 |
34,693,931 | associ central obes lifelong antivir therapi adult live hiv acquir earli childhood littl known regard long term effect antiretrovir arv exposur bodi composit peopl live hiv plwh sinc earli childhood studi explor chang bodi fat distribut relat arv exposur | D015658;D056128 | T033;T047;T184 |
34,693,930 | high burden advers drug reaction isoniazid prevent therapi peopl live hiv tertiari hospit uganda associ factor hiv one import risk factor tuberculosi tb relat morbid mortal isoniazid prevent therapi ipt recommend prevent latent tb reactiv patient hiv howev due multipl therapi comorbid patient predispos advers drug reaction adr lead increas morbid mortal aim studi determin preval associ factor suspect ipt link adr hiv posit patient use ipt | D064420;D015658 | T047;T046;T037 |
34,693,929 | vitro character code variant predict function implic efflux transport multidrug resist protein mrp abcc mrp gene abcc polymorph efflux transport implic drug induc toxic select ten common observ mrp code variant among european experiment character includ nine variant predict deleteri function combin annot depend deplet score assess protein local activ quantifi intracellular accumul two prototyp substrat taurochol acid tca estradiol glucuronid eg hekt express mrp wildtyp variant cellular substrat load optim co transfect uptak transport vm novel variant previous studi tm show reduc activ compar mrp wildtyp eg tca p li gw ke rq moder increas activ substrat depend manner protein express analysi indic reduc cell surfac express vm p tm compar wildtyp reduc activ may result alter surfac express vm intrins activ variant map within nucleotid bind domain mrp gw show trend reduc surfac express p despit transport compar increas wildtyp suggest enhanc intrins activ find suggest moder alter mrp activ six nine predict function variant like differ mechan substrat specif effect cell base studi use multipl known substrat warrant accur predict function variant clinic import transport | D018528;D027425 | T116;T123 |
34,693,928 | contribut apoa apoc cetp abca sik genet variant hypertriglyceridemia develop mexican hiv patient receiv antiretrovir therapi investig impact singl nucleotid polymorph snps apoa apoc cetp atp bind cassett transport sik gene develop hypertriglyceridemia hiv patient antiretrovir therapi | D019380;D015658;D015228 | T047;T121 |
34,693,927 | incorpor gpd genotyp identifi patient gpd defici glucos phosphat dehydrogenas gpd defici common x link enzym disord associ hemolyt anemia exposur fava bean certain medic activ test gold standard detect gpd defici howev test affect various hematolog paramet clinic gpd genotyp includ pharmacogenet array clinic sequenc effort may reconcil activ result patient n enrol institut pharmacogenet test protocol underw clinic gpd genotyp gpd variant algorithm account known interfer activ assay propos develop clinic decis support alert inform prescrib high risk medic prescrib warn gene drug interact recommend therapi alter patient genotyp result patient predict normal gpd activ predict variabl gpd activ predict defici gpd activ patient normal genotyp activ result concord normal gpd phenotyp patient defici genotyp activ result concord defici activ result genotyp reassign phenotyp five patient discord genotyp activ result three switch normal defici two switch defici normal gpd activ genotyp two independ test method use conjunct assign inform gpd phenotyp either method alon | D005955 | T047 |
34,693,926 | concord among differ anticholinerg burden scale risk older popul aim studi evalu concord among anticholinerg scale measur anticholinerg drug exposur risk elder complex chronic patient primari care | D018680 | T121 |
34,693,925 | mental health development disord diagnos foster nonfost children enrol medicaid studi use medicaid claim compar preval mental health disord mhds development disord dds foster nonfost youth | D001289;D001523 | T048 |
34,693,924 | emot behavior problem youth autism high preval impact function emot behavior problem ebp may co occur autism spectrum disord asd impair children function beyond autism symptomatolog compar preval ebp youth without asd evalu uniqu contribut impair asd | D001249;D000067877;D001321;D000066553 | T033;T048;T047 |
34,693,923 | defin describ termin ulcer adult end life integr review author identifi synthes publish primari literatur unavoid skin breakdown end life wound known termin ulcer | D003668;D014456 | T047;T046 |
34,693,922 | abnorm pulmonari function test independ risk factor procedur complic transthorac needl biopsi comput tomographi ct guid transthorac needl biopsi import diagnost tool pulmonari nodul offer less invas altern surgic procedur studi aim better risk stratifi patient undergo procedur analyz pulmonari function test pft imag characterist patient demograph associ complic | D004646;D008175;D055613;D011030;D011656 | T033;T191;T046;T047 |
34,693,921 | human herpesvirus kaposi sarcoma screen manag transplant recipi hhv associ diseas rare potenti fatal transplant recipi import differ exist distribut hhv seropreval might contribut lack uniform approach hhv aim review discuss recent updat screen manag hhv transplant | D019288;D012514 | T191;T005 |
34,693,920 | antifung hypersensit reaction cross reactiv pattern goal articl provid updat understand evid base approach possibl antifung hypersensit includ recognit clinic phenotyp implic cross reactiv diagnost manag strategi immedi delay hypersensit reaction | D000935;D004342 | T195;T046;T121 |
34,693,918 | two novel truncat variant aspm gene identifi nonconsanguin chines famili associ primari microcephali primari autosom recess microcephali mcph rare neurodevelopment disord relat high incid region consanguin marriag wide practic far mcph case report china report clinic molecular characterist two chines mcph patient year old woman proband brother year old man nonconsanguin famili main manifest proband small head circumfer prematur closur fontanell impair concentr moder intellectu disabl proband brother similar symptom hyperact sever slope forehead brain imag reveal global reduct brain size especi frontal lobe bilater anterior horn later ventricl sequenc result reveal patient carri novel nonsens variant ptyr cdelta novel frameshift variant pargserf cdelgg aspm gene variant interpret pathogen silico analysi find help expand mutat spectrum aspm provid new opportun assist tradit clinic diagnosi case atyp characterist | D008607;D008831 | T048;T047;T019 |
34,693,917 | age specif rate time cours gastrointestin nongastrointestin complic associ screeningsurveil colonoscopi rate serious cardiac neurolog pulmonari event attribut colonoscopi poor character background event rate usual account | D011159 | T062 |
34,693,916 | naiv haemophilia mice display differ pattern cytokin profil cytokin profil chang might associ subclin bleed subclin bleed haemorrhag event clinic detect haemophilia reliabl method avail predict subclin bleed investig whether haemophilia mice subclin haemorrhag evalu potenti biomark includ multipl cytokin chang predict subclin haemorrhag plasma nave fviii fix mice wild type counterpart fviii wt fix wt respect measur prothrombin fragment f multipl cytokin haemophilia mice induc hemarthrosi use posit clinic bleed control naiv haemophilia mice display higher level posit bleed control count univari multivari analys cytokin perform compar wild type mice fviii wt vs fix wt pmoll f wide vari haemophilia mous strain fviii vs fix pmoll cytokin vari wide naiv haemophilia b mice signific cytokin comparison haemophilia mice hemarthrosi bleed challeng naiv fviii mice elev pro inflammatori cytokin fix mice elev anti inflammatori cytokin addit interleukin il follow il il tnf mip fviii mice mip follow il il fviii mice exhibit signific differ potenti associ potenti subclin bleed naiv haemophilia mice show elev pro inflammatori cytokin differ pattern repres pro inflammatori cytokin elev nave fviii mice anti inflammatori cytokin fix mice | D006467 | T047 |
34,693,913 | chad vasc score patient covid pneumonia relationship biomark thrombosi inflamm myocardi injuri chad vasc score associ wors prognosi coronavirus diseas covid studi investig laboratori correl increas chad vasc patient covid patient covid stratifi chad vasc group chad vasc group chad vasc group chad vasc found stepwis increas dimer hs troponin hospit mortal across group p dimer hs troponin remain independ associ chad vasc b p b p respect found signific correl dimer c reactiv protein crp group group r p r p r p respect dimer hs troponin group group r p r p r p respect cohort chad vasc independ associ dimer hs troponin increas variabl relationship dimer hs troponin crp within differ chad vasc strata suggest multipl mechan respons dimer increas covid | D000086382;D013927 | T046;T047;T067 |
34,693,908 | subpopul neuron lofc encod previous current reward time choic studi neural dynam later orbitofront cortex lofc shown subset neuron encod distinct aspect behavior valu may project common downstream target howev unclear whether reward histori may subserv lofc well document role learn repres function subpopul lofc previous analyz neural record rat perform valu base decis make task document trial trial learn requir lofc constantinopl et al character function subpopul lofc neuron behavior includ encod task variabl found five distinct cluster lofc neuron either base cluster trial averag peristimulus time histogram psths featur space defin averag condit fire rate align differ task variabl observ weak encod reward attribut stronger encod reward histori anim left right choic reward receipt across cluster one cluster howev encod anim reward histori time short preced choic suggest possibl role integr previous current trial outcom time choic cluster also exhibit qualit similar respons identifi corticostriat project neuron recent studi hirokawa et al suggest possibl role subpopul lofc neuron mediat trial trial learn | D012201 | T041 |
34,693,907 | protein kinas c essenti igg respons cell independ type antigen commens bacteria antigen ag multival repetit structur elicit igg product cell independ manner howev mechan cell independ type ti ag induc igg respons remain obscur report b cell receptor bcr engag ti ag cell depend td ag abl induc transcript aicda encod activ induc cytidin deaminas aid effici class switch igg upon costimul il ifn mous b cell ti ag strong induc phosphoryl protein kinas c pkc pkc mediat aicda transcript induct batf key transcript regul aicda pkc defici mice product igg intact td ag abrog typic ti ag well commens bacteria experiment disrupt gut epitheli barrier result fatal bacteremia thus result reveal novel molecular requir class switch ti respons highlight import homeostat commens specif igg product | D013559 | T040;T070 |
34,693,905 | total hip replac osteoarthr evid base patient orient indic total hip replac thr belong common inpati oper germani procedur perform per year artifici joint still function year year surgeri essenti indic procedur uniform appropri patient orient | D019644;D015207 | T047;T061 |
34,693,902 | salutogenesi nutrit status eat behaviour systemat review assess relationship sens coher soc eat behaviour nutrit status | D005247;D009752 | T040;T033;T055 |
34,693,901 | dietari sodium estim method accuraci limit old new method individu high cardiovascular risk accur easi use method dietari na intak estim popul level lack aim estim mean na intak group level use varieti dietari method dm urinari method um correl h urin collect ucol ii improv accuraci exist dm | D002318;D012982 | T047;T168 |
34,693,900 | preval comparison alcohol candi energi drink snack soda restaur brand product market twitch facebook game youtub game compar evalu preval food beverag market livestream platform twitch facebook game youtub game well examin growth food beverag market platform month period data collect | D000086382;D061215;D061108;D018910 | T047;T073;T170;T168;T067 |
34,693,899 | local urban govern polici facilit healthi environment sustain diet relat practic scope review scope review sought describ polici action urban local govern global implement facilit healthi environment sustain diet relat practic | D009111;D018673 | T092;T170 |
34,693,898 | estim cost effect sodium reduct communiti program studi assess cost effect center diseas control prevent cdc sodium reduct communiti program srcp | D005522;D012982 | T095;T057;T168 |
34,693,896 | mind sexual dysfunct systemat research synthesi throughout previous decad research explor associ mind sexual dysfunct grown exponenti research highlight invers associ mind various sexual dysfunct includ erectil dysfunct hypersexu sexual distress well posit associ mind sexual desir sexual satisfact overal sexual function studi sought describ state extant literatur explor associ mind sexual dysfunct identifi area futur studi within area research inform clinic practic work experienc sexual dysfunct systemat search peer review journal articl reveal final sampl articl collect data includ articl result support invers associ mind various sexual dysfunct addit result highlight current mind sexual dysfunct literatur focus individu experi fulli consid coupl system often impact may contribut mainten sexual dysfunct furthermor result demonstr import includ lgbtq popul futur research extant literatur area focus primarili heterosexu experi | D064866;D012735;D020018 | T048;T046;T041 |
34,693,893 | degrad abil robust antioxid defenc system led sds toler cyanobacterium fischerella sp lmga test toler degrad potenti cyanobacterium fischerella sp lmga surfact sodium dodecyl sulfat sds differ dose sds use growth lower dose sds support growth cyanobacterium wherea higher dose found inhibitori cyanobacterium somehow manag surviv sds howev signific reduct observ pigment protein content substanti accumul carbohydr sds may act osmoprotect surviv cyanobacterium higher dose sds also trigger ros generat lipid peroxid show negat impact psii effici simultan effici ros mitig system sod cat activ also work sds apx enhanc sds furthermor sds degrad potenti investig almost sds degrad th day treatment cyanobacterium henc result suggest due robust antioxid defenc system abil degrad surfact cyanobacterium show signific toler toward sds | D000975;D000458 | T044;T007;T121;T123;T039 |
34,693,892 | mind base intervent older adult dementia mild cognit impair meta analysi systemat review meta analysi examin effect mind base intervent mbis psycholog symptom cognit function qualiti life older adult dementia mild cognit impair mci | D060825;D003704;D064866 | T048;T041 |
34,693,891 | investig critic factor support healthi independ longev proposit conceptu model measur beyond covid pandem studi investig factor support elder citizen perceiv healthi independ longev beyond covid pandem structur equat model conduct dataset collect japan valid propos model six anteced factor found town vibranc mobil transport signific impact wherea health welfar polici communiti bond relat lower impact perceiv healthi longev studi provid conceptu model measur discuss field studi | D000086382 | T047;T067 |
34,693,886 | support vector machin base predict pore form toxin pft use distribut represent reduc alphabet bacteri virul attribut wide varieti factor includ toxin harm host pore form toxin one class toxin confer virul bacteria one promis target therapeut intervent work develop sequenc base machin learn framework predict pore form toxin use distribut represent protein sequenc encod reduc alphabet scheme base conform similar hydropathi index input featur support vector machin svms choic conform similar hydropathi indic base function mechan pore form toxin methodolog achiev accuraci indic conform similar indic flexibl amino acid along hydrophob index captur intrins featur pore form toxin distinguish type transport protein increas understand mechan pore form toxin contribut use mechan inform featur may increas predict accuraci | D001419;D060388 | T007;T066;T081 |
34,693,885 | incorpor biolog network high dimension bayesian surviv analysi use icmm algorithm cox proport hazard model wide use cancer genom research aim identifi gene high dimension gene express space associ surviv time patient increas expert curat biolog pathway challeng incorpor complex network fit high dimension cox model paper consid bayesian framework employ ise prior captur relat among gene repres graph spike slab prior also assign coeffici purpos variabl select iter condit modesmedian icmm algorithm propos implement cox model icmm estim hyperparamet use condit mode obtain coeffici condit median procedur produc coeffici exact zero make model interpret comparison icmm regular cox model carri simul real data compar lasso adapt lasso elast net degreecox icmm yield parsimoni model consist variabl select icmm model also provid smaller number fals posit method show promis result term predict accuraci term comput time among network awar method icmm algorithm substanti faster degreecox even incorpor larg complex network implement icmm algorithm cox regress model provid r packag icmm avail comprehens r archiv network cran | D000465;D023281 | T091;T170 |
34,693,884 | cosmet surgeon portray cosmet procedur instagram content analysi cosmet surgeon post instagram present studi intend explor visual textual content post cosmet surgeon share instagram page order present cosmet surgic non surgic procedur studi employ qualit approach use textual visual content analysi instagram post share cosmet surgeon result demonstr content analyz post categor sub theme cluster around four main theme got bodi imperfect bodi imperfect worrisom cosmet procedur solut provid real surgeri | D061108;D066231 | T097;T170 |
34,693,883 | associ bodi mass index waist circumfer age natur menopaus popul base cohort studi chines women purpos studi investig whether premenopaus bodi mass index bmi waist circumfer wc influenc age menopaus total women age year two communiti cmcs beij cohort recruit follow premenopaus women baselin women data miss final women includ analysi overweight defin bmi kgm central obes defin wc cm age menopaus categor year ror ci p also year ror ci p year ror ci p overweight women combin central obes risk earli menopaus increas | D008593 | T039 |
34,693,882 | novel chimer monoclon antibodi block fentanyl effect alter fentanyl biodistribut mice preval societ impact opioid use disord oud acknowledg public health crisi aggrav current pandem one devast consequ oud opioid overdos death multipl medic avail treat oud given preval societ burden addit well toler effect therapi still need point develop chimer monoclon antibodi mab specif complex fentanyl analog peripheri therebi prevent reach central nervous system addit mab base passiv immunotherapi offer high degre specif drug abus interfer individu abil use medic use treat oud hypothes sequest fentanyl analog peripheri mitig negat effect brain peripher organ studi first report chimer mab fentanyl analog discov engin chimer version identifi select antibodi vitro character vivo anim challeng studi two mab candid high nm bind affin fentanyl analog found effect engag fentanyl peripheri block effect challeng anim result present work constitut major contribut field novel therapeut target oud | D000074322;D009293 | T129;T048;T121;T116 |
34,693,881 | critiqu measur emot empathi first peopl cultur safeti nurs educ systemat literatur review australia undertak cultur safeti educ often evok strong emot respons health student despit potenti emot drive transform learn space measur emot uncommon | D004506;D013338 | T097;T065 |
34,693,880 | motor intent decod upper limb graph convolut network base function connect decod brain intent noninvas measur neural signal recent hot topic brain comput interfac bci motor command movement fine part increas degre freedom control appli extern equip without stimulus decod process classifi one key factor graph inform eeg ignor research paper graph convolut network gcn base function connect propos decod motor intent four fine part movement shoulder elbow wrist hand first event relat desynchron analyz reveal differ four class second function connect construct use synchron likelihood sl phase lock valu plv h index h mutual inform mi weight phase lag index wpli acquir electrod pair differ subsequ gcn convolut neural network cnn perform base function topolog structur time point respect result demonstr propos method achiev decod accuraci four class task besid combin gcn function connect promot develop bci | D062207 | T074 |
34,693,875 | nausea vomit pregnanc possibl correl obsess compuls disord alexithymia possibl correl nausea vomit pregnanc nvp obsess compuls disord ocd alexithymia examin cross section studi cohort pregnant women first trimest pregnanc experienc nvp divid three group accord sever mild moder sever pregnanc uniqu quantif emesi nausea puqe test maudsley obsess compuls disord scale mocq toronto alexithymia scale tas appli score scale compar three group relationship nvp sever ocd alexithymia evalu enrol pregnant women mild moder sever nvp pregnant women mild nvp lower mocq score sever nvp p total score tas higher among subject greater nvp sever p puqe score demonstr signific correl mocq total subsect score tas regardless nvp group studi result show women pronounc ocd andor alexithymia experi somat complaint nvp particular intens first trimest pregnanc reason psychotherapi addit medic treatment could recommend pregnant women sever nvpimpact statement alreadi known subject nvp condit experienc women particular first trimest pregnanc affect psychosomat condit pregnant woman result studi add sever nausea vomit accord puqe test signific associ ocd alexithymia presenc pregnant women first trimest period implic find clinic practic andor research find might demonstr symptom nvp correl ocd well alexithymia longitudin studi requir demonstr clear causal relationship nvp psychiatr symptom ocd alexithymia | D048968;D009771;D011248 | T048;T046;T184 |
34,693,874 | associ vegfa promot polymorph rs rs diabet retinopathi among north central indian subject case control studi diabet mellitus type often describ global pandem st centuri india emerg capit microvascular complic retinopathi associ diabet serious world health problem lead alreadi exist burden blind aim studi determin whether vegf gene polymorph rs rs associ dr north indian | D003924;D003930 | T047 |
34,693,873 | teach medic student psychiatr resid fellow cognit bias lunch go go find way make abstract often obtus concept understand student intern resid fellow crucial pedagog task explain principl practic via person narrat may increas student engag materi accord person essay present person stori lunch date father illustr power confirm select attent bias well concept clinic applic sever element lunch go go narrat use specif explic teach point cognit bias role peopl inner live | D013337 | T097 |
34,693,872 | relationship second trimest amniot fluid plasma level angiopoietin thrombomodulin advers pregnanc outcom object investig matern midtrimest plasma amniot fluid af level angiopoietin ang thrombomodulin tm involv vascular remodel endothelium activ placent disord includ foetal growth restrict fgr preeclampsia pe prospect multiparametr pilot studi conduct perinatolog divis trakya univers popul undergo genet amniocentesi af plasma aliquot kept c elisa assay pregnanc follow end gestat term obstetr result amniot fluid plasma aliquot pregnanc underw genet amniocentesi week gestat analys final data evalu exclud various reason twelv subsequ develop fgr complic pe control group n consist women deliv th week uncompl outcom midtrimest matern ang level af plasma also tm level plasma found signific increas pregnanc subsequ develop fgr pe p midtrimest ang rise plasma af midtrimest tm signific increas plasma compart pe group compensatori mechan may precursor placent disord includ fgr peimpact statement alreadi known subject known angiopoietin ang import role placent angiogenesi vascular remodel tm receptor ang play protect role pregnanc prevent uteroplacent circul thrombosi result studi add present studi demonstr midtrimest matern plasma ang tm amniot fluid af ang level signific higher pe fgr group uncompl group midtrimest af tm level signific higher pe group control group implic find clinic practic andor research clinic practic high level midtrimest ang tm plasma may use predict fgr pe although amniocentesi practic clinic use level two marker af plasma compart may contribut explain pathophysiolog fgr pe | D000653;D011225 | T170;T031;T046 |
34,693,871 | studi effect ozon therapi treatment experiment induc kerat candida albican rabbit present studi antifung activ ozon oliv oil ozo ozon distil water odw treatment experiment induc kerat c albican rabbit investig | D002177;D015821;D007634;D010126 | T047;T103 |
34,693,869 | associ singl nucleotid polymorph vegf gene pelvic lymph node metastasi patient earli stage cervic cancer cervic cancer patient earli stage cervic cancer ecc divid pelvic lymph node pln metastasi non pln metastasi group singl nucleotid polymorph snp genotyp vegf gene conduct plasma vegf level measur multivari analysi perform assess correl snps vegf gene pln metastasi found snp vegf rs independ associ pln metastasi gg cg genotyp increas suscept pln metastasi compar cc genotyp moreov higher gg genotyp cg genotyp plasma vegf level lowest cc genotyp intermedi gc genotyp highest gg genotyp summari snp vegf rs affect suscept pln metastasi patient ecc gg cg genotyp increas suscept compar cc genotyp potenti mechan associ elev plasma vegf levelsimpact statement alreadi known subject posit express vascular endotheli growth factor vegf correl higher risk lymph node metastasi among cervic cancer patient vegf level patient pelvic lymph node pln metastasi signific higher without pln metastasi addit singl nucleotid polymorph snps vegf gene indic correl individu suscept tumour express protein product vegf result studi add snp vegf rs independ associ pln metastasi patient earli stage cervic cancer ecc gg cg genotyp vegf rs increas suscept pln metastasi compar cc genotyp plasma vegf level lowest cc genotyp intermedi gc genotyp highest gg genotyp implic find clinic practic andor research snp vegf rs affect suscept pln metastasi patient ecc potenti mechan associ elev plasma vegf level | D008207;D020641;D002583;D042461 | T086;T191;T116;T123 |
34,693,868 | dft base qsar studi quinolon triazol deriv antibacteri agent qsar model perform quinolon triazol deriv gram posit staphylococcus aureus gram negat pseudomona aeruginosa bacteria molecular structur optim use dftblyp method g basi set molecular descriptor extract use quantum mechan calcul hierarch cluster analysi perform ration subset divis initi dataset divid calibr valid set model done stepwis mlr method two bacteria intern extern valid method confirm robust predict obtain model accord obtain model aureus r r ext q loo four descriptor partial atom charg n atom triazol c quinolon nucleus carbonyl bond length c nmr chemic shift carboxyl acid found descriptor control activ accord obtain model p aeruginosa r r ext q loo atom partial charg carbonyl lumo homo energi gap logp found descriptor highest correl antibacteri activ final new compound higher activ design propos | D015363 | T109 |
34,693,867 | bifunct molecul target sar cov spike polymer ig receptor display neutral activ mucos enrich global health crisi econom toll covid necessit panopli strategi treat sar cov infect date treatment option exist although neutral antibodi spike glycoprotein proven effect infect initi mucosa propag main site throughout cours diseas block virus mucos milieu effect howev administr biolog mucosa present substanti challeng describ bifunct molecul combin singl domain variabl region bind polymer ig receptor pigr sar cov spike protein via addit ace extracellular domain ecd hypothesi behind design pigr transport molecul circul mucos surfac ace ecd would act decoy receptor ncov bifunct molecul bind sar cov spike glycoprotein vitro effici transcytos across lung epithelium human tissu base analys design featur ace tether c terminus fc induc antibodi depend cytotox pigr express cell molecul thus repres potenti therapeut modal system administr neutral anti sar cov molecul mucosa | D000914;D019056;D057127 | T192;T129;T116 |
34,693,866 | microbi contribut calor restrict trigger regul intestin level glutathion transferas taurin bile acid recent show calor restrict cr trigger increas level free taurin taurin conjug bile acid ba taurin conjug intestin mucosa decreas glutathion gsh level wild type male mice current project decid investig whether microbiota involv respons cr deplet gut bacteria antibiot treatment diminish cr specif increas level free taurin conjug well upregul express activ gsh transferas gst intestin mucosa diminish cr relat increas bas level liver plasma intestin mucosa transplant microbiota cr mice ad libitum fed mice trigger cr like chang mgst express level taurin taurin conjug mucosa ileum show first time microbiota contribut intestin respons cr trigger chang ba taurin gst level | D031204;D000069196 | T033;T007;T001;T061 |
34,693,863 | late effect care childhood brain tumor survivor qualiti improv initi childhood adolesc brain tumor survivor risk long term consequ therapi review adher long term follow ltfu guidelin assess provid perspect studi need experi qualiti life qol pediatr malign brain tumor survivor mcmaster children hospit neuro oncolog clinic ltfu area improv evalu use anonym health provid need assess questionnair cancer care experi questionnair cceq cancer worri scale cws self manag skill scale smss pedsql measur parentspati need qol individu care plan base children oncolog group cog ltfu guidelin base respons staff perceiv area improv includ increas multi disciplinari particip improv patient educ increas surveil therapi relat late effect thirti two famili particip felt receiv high qualiti care mean cancer worri score low survivor report limit self manag skill requir support medic need activ daili live overal median qol score good parent report survivor util survivorship guidelin assess patient caregiv health provid implement improv provis neuro oncolog survivorship care lesson learn may assist ltfu program | D001932;D009369 | T191 |
34,693,862 | techniqu surgic manag ovarian endometrioma affect ovarian reserv narrat review endometriot ovarian cyst one common gynecolog disord found reproduct age infertil women aim review summaris inform regard effect surgic treatment endometrioma ovarian reserv women endometrioma ovarian reserv decreas compar similar age healthi women surgic manag techniqu caus addit reduct evid suggest laparoscop ovarian cystectomi via strip prefer surgic techniqu manag endometrioma compar excisionalabl techniqu field pain improv spontan pregnanc rate ovarian cyst recurr ablat techniqu combin techniqu three step approach demonstr less declin anti mllerian hormon postop success oper involv remov ovarian patholog also mainten ovarian function futur reproduct potenti patient counsel risk surgeri manag plan individualis patient symptom reproduct goal | D004715;D007247;D010535;D010048;D065851 | T191;T047;T046;T042;T060;T061;T033 |
34,693,861 | pregnanc aggrav critic covid infect obes asthmat peripartum woman peripartum covid mortal case report coronavirus diseas covid sweep world inform covid evolv rapid interim guidanc multipl organis constant updat expand earli discoveri covid report pregnanc affect progress diseas sever recent centr diseas control prevent cdc report pregnanc risk factor covid sever current case report present peripartum covid posit mortal case | D001249;D000086382 | T047;T067 |
34,693,860 | microrna regul adipogen differenti bovin intramuscular preadipocyt target camkk intramuscular fat one import palat attribut beef carcas primari determin beef qualiti research adipogenesi mechan would provid new insight intramuscular fatti deposit role microrna investig bovin adipogen differenti reveal mir express exist variabl bovin major tissu organ rt qpcr predict mir target camkk ampk kinas diana tool better research primari preadipocyt stabl transfect regul express mir construct lentivir vector gfp gene analys qpcr show ppar adiponectin mrna level increas cebp pref camkk mrna level decreas adipogen differenti mir overexpress preadipocyt prolifer becam slower cellular lipid droplet ppar cebp mrna level higher pref adiponectin camkk lower control group luciferas assay western blot analysi valid mir bind nucleotid site untransl region camkk inhibit mrna protein express camkk find suggest mir promot adipogen differenti bovin intramuscular preadipocyt target camkk via ampk signal pathway | D050156;D035683 | T044;T114;T123 |
34,693,858 | explor salutogen factor support oral health elder explor associ salutogen factor select clinic outcom variabl oral health elder combin antonovski salutogen theori lalond health field concept | D060685 | T041 |
34,693,857 | post legal drug communic examin colorado cannabi campaign colorado legal marijuana use recreat purpos adult goal examin first major communic campaign call good know mount state govern object inform public regard regulatori safeti precaut surround newli legal use method assess content campaign central messag qualit compar major theme term criteria develop literatur campaign goal result minor except lack audienc segment limit focus generat knowledg colorado good know campaign rate well assess specif criteria effect drug communic campaign well goal conclus conclud although minor limit campaign polici maker activist think proactiv messag content state legal immin research legal drug use messag need occur | D002188;D006213;D008385;D000074609 | T121;T002;T109;T055;T167;T131;T048 |
34,693,854 | effect aspirin patient nonvaricos upper gastrointestin bleed risk factor analysi paper aim explor effect aspirin hospit mortal patient nvugib | D001241;D006471 | T047;T121;T109;T046 |
34,693,853 | listen effect multitalk speech segreg talker identif six decad ago cherri drew attent call cocktail parti problem challeng segreg speech one talker other speak time problem activ research ever sinc time one observ elud explan wide variat perform individu listen variat replic four major experiment factor known impact perform differ task talker segreg vs identif differ voic featur talker pitch vs locat differ voic similar uncertainti talker inform mask presenc absenc linguist cue effect factor segreg natur spoken sentenc synthes vowel larg elimin psychometr function relat perform individu listen ideal observ ideal effect listen remain differ slope function fix effect littl within listen variabl estim slope random effect result make case consid listen factor multitalk segreg identif equal status major experiment variabl | D013060;D013067 | T040;T041;T054 |
34,693,852 | emerg cellular molecular interact lung microbiota lung diseas discoveri lung microbiota studi pulmonari health diseas becom vibrant area emerg research interest thus far studi describ lung microbiota composit lung diseas quit well studi indic alter lung microbi communiti relat onset develop lung diseas vice versa howev under mechan particular cellular molecular link still larg unknown review highlight current progress complex cellular molecular mechan lung microbiom interact immun homeostasi pulmonari diseas pathogenesi advanc understand elabor function lung microbiota lung diseas hope work attract attent still young yet promis field facilit identif new therapeut target provid innov therapi addit accur standard base methodolog technolog breakthrough critic propel field forward ultim achiev goal maintain respiratori health | D008171;D064307 | T032;T001;T047;T028 |
34,693,851 | scientif regulatori polici committe point consid fixat trim section nonrod eye ocular tissu examin ocular general toxic studi work group societi toxicolog patholog scientif regulatori polici committe conduct technic scientif review current practic relat fixat trim section nonrod eye identifi key point speci specif anatom landmark consid prepar evalu eye rabbit dog minipig nonhuman primat ocular general toxic studi topic address point consid articl includ determin situat comprehens evalu globe andor associ extraocular tissu implement expand ocular sampl constitut expand ocular sampl addit manuscript highlight practic aspect fix trim section eye ensur adequ histopatholog evalu major ocular structur includ cone dens area visual streakmaculafovea retina rabbit dog minipig nonhuman primat current regulatori expect ocular toxic studi box see text | D006652;D018675 | T059;T060 |
34,693,849 | life thyroid cancer role thyroglobulin thyroglobulin antibodi postop follow differenti thyroid carcinoma dtcs treat near total thyroidectomi radioiodin therapi recent use high sensit thyroglobulin hstg assay simplifi dtc follow improv patient qualiti life limit approach current appli low risk patient requir interpret tg result differ clinic scenario final tg assay hamper interfer thyroglobulin autoantibodi tgab | D013954;D013964 | T116;T191;T121;T125 |
34,693,848 | design phase ii clinic trial friedreich ataxia friedreich ataxia frda autosom recess disord caus defici frataxin essenti mitochondri protein involv iron sulfur cluster biogenesi oxid phosphoryl process frda notabl affect heart sensori neuron spinal cord cerebellum brain region manifest clinic ataxia sensori loss dysarthria spastic hypertroph cardiomyopathi therapeut approach frda consist two differ approach augment restor frataxin product modul varieti downstream process relat mitochondri dysfunct includ reactiv oxygen speci product ferroptosi nrf activ | D005621 | T047 |
34,693,846 | role gut microbiom prevent diagnosi treatment gestat diabet mellitus gestat diabet mellitus gdm common metabol diseas associ matern foetal complic gut microbiom might particip gdm pathogenesi possibl biolog link includ short chain fatti acid incretin hormon bile acid homeostasi peroxisom prolifer activ receptor gamma defici gut microbiom differ patient gdm even earli pregnanc differ observ five year postpartum patient enrich verrucomicrobia phylum christensenellacea lachnospiracea famili haemophilus prevotella actinomyc collinsella ruminococcus genera pregnanc clostridial order alistip faecalibacterium blautia eubacterium roseburia genera deplet howev great heterogen review studi scientif data use gut microbiom characterist relat biomark gdm risk stratif diagnosi scarc probiot synbiot test prevent treatment gdm limit efficaci futur studi explor effect probiot administr first trimest pregnanc valu adjuv therapi | D016640;D000069196;D019936 | T007;T047;T001 |
34,693,845 | decreas anti pariet cell antibodi titer advanc phase autoimmun gastriti autoimmun gastriti aig histolog classifi three phase accord sever oxynt mucos atrophi earli florid end phase studi aim clarifi relationship aig phase anti pariet cell antibodi titer | D001327;D005756;D016481 | T047 |
34,693,844 | nebivolol allevi liver damag caus methotrex via akthifeno signal despit wide clinic indic methotrex mtx use limit serious side effect includ liver toxic mtx shown caus tissu damag main oxid stress also inflamm apoptosi thus nebivolol neb antioxid antiapoptot properti thought effect mtx induc injuri studi aim evalu effect neb mtx induc liver toxic via akthypoxia induc factor alpha hif endotheli nitric oxid synthas eno signal pathway rat divid three group control mtx neb singl dose mtx mgkg intraperiton given rat first day experi neb mgkg daili oral gavag given treatment group week end experi blood taken aspart transaminas ast alanin aminotransferas alt total bilirubin bil analys liver tissu harvest biochem total oxid status tos total antioxid status tas genet pcr analys akt eno hifa histolog hemotoxylin eosin masson trichom period acid schiff asien blue reticulin histolog cd immunohistochem stain analys mtx increas level tos valu ast alt bil level decreas express akthifeno neb treatment revers chang mark via decreas inflamm nitric oxid product conclus neb treatment signific preserv liver decreas oxid level inflammatori paramet hifeno signal due antioxid properti neb use liver injuri model share pathway | D056486;D008727 | T047;T121;T037;T109 |
34,693,843 | assess dose depend biochem cytotox zein coat mgo nanowir male femal albino rat introduct recent zein coat mgo nanowir synthes could promis effect antimicrobi compound combin prepar divers new dental formul howev defici inform concern toxicolog profil regard human health object vivo studi aim explor hepato nephrotox low versus high dose zein coat mgo nanowir rat materi method day recurr dose toxic research carri wistar rat divid main group male femal n group subdivid subgroup control mgo zein nanowir low dose mgo zein nanowir high dose low dose use mgkg high dose use mgkg result result show mgo zein nanowir dose affect electrolyt level compar control level also produc signific alter liver function marker rat gender mgo zein nanowir dose produc effect alter serum creatinin treat rat gender moreov minim histolog alter observ dose mgo zein nanowir liver kidney gender conclus base observ safeti zein coat mgo nanowir util effect antimicrobi compound combin prepar divers new dental formulationskey messagesmgo nps global use multipl field includ therapeut fieldzein wide pharmaceut applic especi coat tablet sugarther cytotox studi investig mgo zein nanowir safeti | D053770 | T073 |
34,693,840 | pregnanc month birth begin mother infant relationship matern perspect earli posit mother child relationship central factor develop psycholog balanc person studi aim identifi risk protect factor develop balanc matern infant postnat attach explor associ matern infant attach prenat postnat variabl potenti implic develop earli bond matern foetal prenat attach social support memori parent care romant attach dyadic adjust pariti breastfeed plan pregnanc woman infant age difficulti deliveri | D009034;D009035 | T092;T054;T099 |
34,693,839 | still role talimogen laherparepvec vec advanc melanoma indirect efficaci comparison vec plus ipilimumab combin therapi versus vec alon salvag therapi unresect metastat melanoma talimogen laherparepvec vec improv overal surviv os unresect stage iiibc iv melanoma vec may synergist effect ctla inhibitor absenc trial compar vec ipilimumab vec ipi vec appli novel indirect comparison method use extrapol os curv estim os outcom simul trial compar regimen stage iiibc iv unresect melanoma | D008545;D050130;D012878 | T191;T061 |
34,693,838 | systemat review meta analysi efficaci vancomycin taper puls regimen clostridioid difficil infect vancomycin drug choic treat clostridioid difficil infect cdi compar cdi resolut vancomycin taper puls taper puls regimen | D003015;D014640 | T116;T047;T037;T195 |
34,693,837 | mortal patient crohn diseas rebro sweden studi suggest reduc life expect patient crohn diseas cd compar general popul evid howev inconsist | D003424 | T047 |
34,693,834 | roza new comprehens metric evalu classif system mani metric accuraci rate acc area curv auc jaccard index ji cohen kappa coeffici avail measur success system pattern recognit machinedeep learn system howev superior one system one determin base mention metric system success use one metric one moreov metric insuffici number sampl class unequ imbalanc data case natur use metric sensibl comparison made two given system present studi comprehens fair accur roza roza mean rose persian differ permut metric use superimpos polygon format look like flower name roza metric introduc evalu classif system metric facilit comparison system express summari mani metric singl valu verifi stabil valid metric conduct comprehens fair accur comparison system roza metric system test condit calcul comparison made system test three differ strategi three differ dataset consid result show perform system summar singl valu roza metric use system includ classif process power metric | D000069550 | T066 |
34,693,829 | chronic kidney diseas affect surgic outcom prognosi patient gastric cancer meta analysi purpos meta analysi evalu impact chronic kidney diseas short term complic long term surviv patient gastric cancer | D051436;D013274 | T191;T047 |
34,693,828 | associ spike extern train load shoulder injuri competit adolesc tenni player smash cohort studi studi examin associ acut chronic workload ratio acwr complaintsinjuri young tenni player primari aim studi investig accumul extern workload spike acwr tenni train match play fit train see high low workloadag ratio associ rate shoulder complaintsinjuri competit adolesc tenni player addit aim report incid complaintsinjuri stratifi sex level play describ shoulder injuri characterist | D001265;D000070599;D013715 | T056;T037 |
34,693,827 | internet survey factor associ care seek behaviour peopl chronic musculoskelet pain japan purpos mani peopl chronic musculoskelet pain cmp seek healthcar convent complementari altern medicin howev treatmenttherapi alway adequ patient often chang healthcar provid patient left untreat studi clarifi care seek behaviour explor factor behind behaviour peopl cmp method use japanes cross section onlin survey particip age year non cancerfractur cmp last month present month interf daili live activ andor work enrol summar analys characterist factor associ choic healthcar provid inform socio demograph includ employ abil use healthcar includ incom need healthcar includ pain intens use logist regress model result among respond consult physician complementari altern medicin practition untreat respond moder sever pain visit physician regular employ high incom visit complementari altern medicin less respond moder sever pain untreat found associ respect healthcar use versus untreat conclus peopl sever condit higher incom regular employ less sever condit visit physician complementari altern medicin practition none respect appli result type healthcar provid may possibl treat patient appropri | D059352 | T033 |
34,693,823 | import surgic assembl techniqu engag modular taper fret corros modular taper junction total hip replac thr lead implant failur identifi clinic concern receiv increas interest recent year mani paramet thought affect perform taper junction assembl process one consist identifi direct impact despit assembl process use surgeon thr surgeri differ suggest ideal process exampl taper junction cut tool push togeth rather impact ensur much concentr possibl male femal taper load axi studi devis six simpl assembl methodolog investig surgic variat affect success compress fit achiev taper interfac compar control assembl method design repres ideal scenario key find studi suggest success repeat engag achiev quasi static load male femal taper concentr load axi shown greater disassembl assembl forc ratio assembl use ideal process compar use method closer use surgeon intraop find studi use help inform new surgic instrument improv surgic assembl method | D019644;D006622 | T074;T061 |
34,693,822 | bacteremia system lupus erythematosus risk factor clinic microbiolog characterist outcom largest singl center retrospect cohort japan patient system lupus erythematosus sle infect especi bacteremia occur throughout cours diseas often fatal evalu characterist patient bacteremia sle | D016470;D008180 | T047 |
34,693,819 | life threaten sustain hypocalcemia follow denosumab use metastat prostat cancer prostat cancer second frequent diagnos cancer among men worldwid skelet relat event sre like patholog fractur spinal cord compress common seen metastat prostat cancer denosumab monoclon antibodi act inhibit osteoclast mediat bone resorpt bone metastasi solid tumor reduc bone turnov destruct howev increas risk life threaten denosumab induc hypocalcemia incid | D050071;D001859;D006996;D016609;D011471 | T191;T047;T121 |
34,693,818 | mechan manag prothrombot state covid diseas novel sever acut respiratori syndrom viral diseas outbreak due sar cov rapid evolv diseas repres one greatest medic challeng recent time believ sar cov migrat bat intermedi host human articl aim mechan manag prothrombot state covid posit patient tri present sar cov virus induc thromboembol event incid thromboembol event also tri depict anticoagul manag patient well postdischarg plan follow invas type pneumocyt sar cov virus critic cours ill result activ immun cell lead elev cytokin subsequ activ cell macrophag infiltr infect myocardi cell caus direct myocardiocyt toxic develop arrhythmia hypoxia hypotens clinic cours caus mismatch myocyt oxygen suppli workload demand result cardiac distress sar cov affect endotheli cell pericyt lead sever micro macrovascular dysfunct togeth oxygen suppli demand mismatch immun hyperrespons potenti caus destabil plaqu ruptur caus acut coronari syndrom mechan injuri includ myocard pericard stress cardiomyopathi vascul dic dissemin intravascular coagul microthrombi sar cov enter cell spike protein whose surfac unit bind ace receptor host cell type ii transmembran serin proteas tmprss histon acetyltransferas hat host cell proteas recruit virus cleav ace surfac protein facilit viral entri therefor tmprss hat could target potenti drug sar cov sar cov use rna depend rna polymeras prolifer target remdesivir current approv emerg use food drug administr fda need adopt multifacet approach combat sar cov present sever challeng includ medic psycholog socioeconom ethic covid biggest calam st centuri need keen understand pathophysiolog clinic implic develop prevent measur therapeut modal | D000086382 | T047;T067 |
34,693,817 | infer overlap coeffici binorm approach altern overlap coeffici ovl measur similar two distribut overlap area distribut function given intuit descript eas visual represent straightforward depict amount overlap two correspond histogram base sampl measur one two distribut develop accur method confid interv construct use appli research overlap coeffici receiv scant attent literatur sinc lack readili avail softwar implement inferenti procedur cover whole rang distribut scenario two under distribut miss method parametr non parametr develop articl r code provid implement parametr approach base binorm model show better perform appropri use wide rang distribut scenario method assess larg simul studi illustr use dataset studi human immunodefici virus relat cognit function assess | D015233;D012984 | T170;T073;T090;T081 |
34,693,816 | ambassador project evalu five year nationwid leadership program bridg gap polici district nurs practic district nurs crucial posit healthcar provis expect use leadership practic ensur optim qualiti patient care better equip leadership program name ambassador project develop support develop liaison role polici district nurs practic research aim evalu differ perspect impact nationwid five year leadership program district nurs organiz region societ level mix method studi conduct use two focus group base peer peer shadow n semistructur interview n onlin questionnair n analysi show impact nationwid leadership program district nurs perceiv predomin posit nurs experienc increas courag assert profession pride leadership skill obtain confid repres group district nurs organiz region societ level speak various key stakehold healthcar system abl bridg gap among daili practic policymak polit use translat shape action inform term suit need involv | D003695;D007857 | T058;T093;T054;T078 |
34,693,815 | finit element model energi store return prosthet foot implic stiff rollov shape energi store return esar prosthet feet show continu improv last year despit standard guidelin still miss achiev optim foot design term perform one import design paramet esar feet rollov shape ros repres foot center pressur cop path shank base coordin system stanc ros object describ foot behavior accord stiff depend foot geometri materi work present develop finit element model methodolog abl predict stiff characterist esar foot ros valid model perform well known commerci avail prosthet foot bench test realist walk scenario obtain result confirm error stiff estim ros evalu underlin propos method power tool abl replic mechan behavior prosthet foot | D000674;D001186 | T074;T101 |
34,693,813 | extern train load associ back pain competit adolesc tenni player result smash cohort studi young tenni player high load spine high train volum relat age associ high lifetim preval back pain primari aim studi investig accumul extern workload spike acut chronic workload ratio acwr tenni train match play fit train high low workloadag ratio associ back pain event competit adolesc tenni player addit aim report incid back pain stratifi sex level play describ characterist player back pain | D013715 | T056 |
34,693,812 | relationship serum lipopolysaccharid bind protein level diseas activ clinic characterist paraguayan patient system lupus erythematosus system exposur bacteri compon like lipopolysaccharid lps among non genet factor could involv onset progress system lupus erythematosus sle lipopolysaccharid bind protein lbp particip recognit lps inflammatori respons investig lbp sle patient relationship diseas activ sle phenotyp | D008070;D008180 | T047;T109 |
34,693,811 | felin cardiomyopathi hypertroph cardiomyopathi hypertroph cardiomyopathi hcm common form felin cardiomyopathi observ clinic may affect approxim domest cat popul primarili subclin diseas fortun sever hcm lead heart failur arteri thromboembol ate occur small proport cat | D009202;D002312;D002371 | T047 |
34,693,806 | felin cardiomyopathi general concept felin cardiomyopathi preval type heart diseas adult domest cat sever form identifi see part hypertroph cardiomyopathi hcm common clinic cardiomyopathi often indistinguish cat subclin cardiomyopathi may may characterist physic examin find eg heart murmur gallop sound radiograph cardiomegali cat sever diseas may develop sign heart failur eg dyspnea tachypnea system arteri thromboembol ate eg pain paralysi sudden death possibl treatment usual alter progress subclin clinic diseas often treatment approach clinic sign appar regardless type cardiomyopathi howev differenti cardiomyopathi normal variat may import prognost | D009202;D002312;D002371;D006331;D006333 | T047;T046 |
34,693,805 | felin cardiomyopathi cardiomyopathi hcm although felin hypertroph cardiomyopathi hcm occur common dilat cardiomyopathi dcm restrict cardiomyopathi rcm arrhythmogen right ventricular cardiomyopathi arvc left ventricular noncompact lvnc cardiomyopathi nonspecif phenotyp ncm former unclassifi cardiomyopathi recogn domest cat | D009202;D002312;D002371;D054556 | T047 |
34,693,804 | terror strike night reflect overnight call shift respons overnight call pager nerv wrack particular cpe student new chaplainci reflect attempt refram terror may associ night time draw spiritu john cross offer encourag wish work greater open equanim courag | D010327 | T091;T058 |
34,693,803 | system lupus erythematosus pregnanc retrospect singl center studi pregnanc portug system lupus erythematosus sle life threaten disord affect women reproduct age evalu clinic impact pregnanc cohort portugues sle patient risk factor associ matern fetal advers outcom | D000022;D016736;D008180;D008181;D011248 | T033;T047;T046 |
34,693,802 | key factor decis make ecl binat factori survey extracorpor life support ecl provid support patient cardiopulmonari failur refractori convent therapi ecl potenti life save associ sever complic decis make initi ecl must therefor care consid patient ecl potenti benefit despit consequ | D015199 | T061 |
34,693,801 | method model excess mortal across england covid pandem excess mortal import measur scale coronavirus pandem includ death caus direct pandem death caus unintend consequ contain delay access care postpon healthcar provis popul england multipl group produc measur excess mortal pandem paper describ data method use five differ approach estim excess mortal compar estimatesth fundament principl estim excess mortal describ well key common differ five approach two base date registr quasi poisson model offset year averag three base date occurr poisson model without offset european monitor excess mortal model synthet control model comparison estim excess mortal made period march march two wave pandem occur within time periodmodel estim strike similar first wave pandem though larger differ observ second wave model adjust reduc circul winter infect produc higher estim excess compar model adjust reduc circul winter infect captur effect reduc winter ill result mobil restrict period none estim captur mortal displac therefor may underestim excess current time though extent occur yet identifi model use differ approach address variat data avail stakehold requir measur variat estim reflect differ date interest popul denomin paramet model relat season trend | D000086382;D058873 | T047;T067 |
34,693,800 | spiritu transform han four level transfer self psycholog purpos articl research han oppress feel korea spiritu approach includ self psycholog han oppress feel korean societi han caus split place begin heal one invest one instinctu energi right place feebl self accord one deepest need spot fragil mani korean suffer decept self imag feel deserv love care vicious han ridden circl korean attain healthi self object experi longer feel fragil | D010327;D019455 | T091;T058;T078 |
34,693,798 | popul high risk cervic cancer guangxi provinc find two screen project minor area south china analys posit rate low grade lsil high grade hsil squamous intraepitheli lesion cervic cancer cc identifi group high risk cc guangxi | D018290;D002583 | T191 |
34,693,797 | neighborhood level predictor sexual violenc across intim partner non intim partner relationship case control studi ampl research explor individu factor associ sexual violenc yet individu dyadic environment influenc intim partner sexual violenc ipsv occur larger context non intim partner violenc nipsv remain relat unexplor current studi aim determin extent counti level indic combin individu dyadic factor associ sexual violenc across relationship type report ipsv nipsv case obtain tennesse bureau investig tbi onlin incid base report system counti level variabl indic neighborhood physic disord violent crime incom inequ firearm preval communiti alcohol use pattern retriev onlin resourc counti health rank roadmap use nest case control design determin signific sexual violenc risk within younger cohort across relationship type find three signific counti level factor incom inequ rate firearm fatal percentag femal resid suggest prevent intervent effort includ target younger age group ipsv nipsv educ develop resourc rang relat partner improv legal access law enforc train report continu examin role firearm | D000066511;D012742 | T037;T048;T053 |